At-home Administration of Gantenerumab by Care Partners to People with Early Alzheimer's Disease: Feasibility, Safety and Pharmacodynamic Impact.

Authors: Boess, Frank G., Scelsi, M. A., Grimmer, T., Perry, R. J., Tonietto, M., Klein, G., Hofmann, C., Salami, M., Wojtowicz, J., Lansdall, C. J., Lane, C., Kerchner, G. A., Smith, J., Doody, R. S.

Source: Journal of Prevention of Alzheimer's Disease; May2024, Vol. 11 Issue 3, p537-548, 12p

Impact of comorbidities on pharmacotherapy of painful diabetic neuropathy in clinical practice

Authors: Ziegler, Dan, Schneider, Edith, Boess, Frank G., Berggren, Lovisa, Birklein, Frank

Source: In Journal of Diabetes and Its Complications September-October 2014 28(5):698-704

Adherence to Initial PDE5 Inhibitor Treatment: Randomized OpenLabel Study Comparing Tadalafil Once a Day, Tadalafil on Demand, and Sildenafil on Demand in Patients with Erectile Dysfunction

Authors: Buvat, Jacques ^*, Büttner, Hartwig ^*, Hatzimouratidis, Konstantinos, Vendeira, Pedro A.S., Moncada, Ignacio, Boehmer, Michael, Henneges, Carsten, Boess, Frank G.

Source: In The Journal of Sexual Medicine June 2013 10(6):1592-1602

EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors

Authors: Prickaerts, Jos, van Goethem, Nick P., Chesworth, Richard, Shapiro, Gideon, Boess, Frank G., Methfessel, Christoph, Reneerkens, Olga A.H., Flood, Dorothy G., Hilt, Dana, Gawryl, Maria, Bertrand, Sonia, Bertrand, Daniel, König, Gerhard

Source: In Neuropharmacology 2012 62(2):1099-1110

Tolerability aspects in duloxetine-treated patients with depression: should one use a lower starting dose in clinical practice?

Authors: Wilhelm, Stefan, Boess, Frank G, Hegerl, Ulrich, Mergl, Roland, Linden, Michael, Schacht, Alexander, Schneider, Edith

Source: Expert opinion on drug safety. 11(5):699-711

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100103346906.0x000001&indx=1&recIds=ETOCvdc_100103346906.0x000001

Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues

Authors: Lakics, Viktor, Karran, Eric H., Boess, Frank G.

Source: In Neuropharmacology 2010 59(6):367-374

The Novel α7 Nicotinic Acetylcholine Receptor Agonist N-[(3 R)-1-Azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide Improves Working and Recognition Memory in Rodents

Authors: Boess, Frank G. ¹, De Vry, Jean ², Erb, Christina ³, Flessner, Timo, Hendrix, Martin, Luithle, Joachim, Methfessel, Christoph, Riedl, Bernd, Schnizler, Katrin ⁴, van der Staay, Franz-Josef ⁵, van Kampen, Marja ⁶, Wiese, Welf Burkhard, Koenig, Gerhard ^{7, *}

Source: In The Journal of Pharmacology and Experimental Therapeutics May 2007 321(2):716-725

Inhibition of phosphodiesterase 2 increases neuronal cGMP, synaptic plasticity and memory performance

Authors: Boess, Frank G., Hendrix, Martin, van der Staay, Franz-Josef, Erb, Christina, Schreiber, Rudy, van Staveren, Wilma, de Vente, Jan, Prickaerts, Jos, Blokland, Arjan, Koenig, Gerhard

Source: In Neuropharmacology 2004 47(7):1081-1092

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.

Authors: Pagano, Gennaro, Boess, Frank G., Taylor, Kirsten I., Ricci, Benedicte, Mollenhauer, Brit, Poewe, Werner, Boulay, Anne, Anzures-Cabrera, Judith, Vogt, Annamarie, Marchesi, Maddalena, Post, Anke, Nikolcheva, Tania, Kinney, Gene G., Zago, Wagner M., Ness, Daniel K., Svoboda, Hanno, Britschgi, Markus, Ostrowitzki, Susanne, Simuni, Tanya, Marek, Kenneth

Source: Frontiers in Neurology; 10/1/2021, Vol. 12, p1-17, 17p

Subject Terms: PARKINSON'S disease, TREMOR, DISEASE progression, MONOAMINE oxidase, DIAGNOSIS, MOVEMENT disorders

Geographic Terms: PASADENA (Calif.)

This result is not displayed to guests.
Login for full access.

Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti–α-Synuclein Monoclonal Antibody, in Patients With Parkinson Disease: A Randomized Clinical Trial.

Authors: Jankovic, Joseph, Goodman, Ira, Safirstein, Beth, Marmon, Tonya K., Schenk, Dale B., Koller, Martin, Zago, Wagner, Ness, Daniel K., Griffith, Sue G., Grundman, Michael, Soto, Jay, Ostrowitzki, Susanne, Boess, Frank G., Martin-Facklam, Meret, Quinn, Joseph F., Isaacson, Stuart H., Omidvar, Omid, Ellenbogen, Aaron, Kinney, Gene G.

Source: JAMA Neurology; Oct2018, Vol. 75 Issue 10, p1206-1214, 9p

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Corrigendum to “Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues” [Neuropharmacology 59 (2010) 367–374]

Authors: Lakics, Viktor, Karran, Eric H., Boess, Frank G.

Source: In Neuropharmacology April 2013 67:532-532

Investigation of stretching behaviour induced by the selective 5-HT6 receptor antagonist, Ro 04-6790, in rats.

Authors: Bentley, Jane C, Bourson, Anne, Boess, Frank G, Fone, Kevin C F, Marsden, Charles A, Petit, Nadine, Sleight, Andrew J

Source: British Journal of Pharmacology; Apr1999, Vol. 126 Issue 7, p1537-1542, 6p

Involvement of 5-HT6 receptors in nigro-striatal function in rodents.

Authors: Bourson, Anne, Boess, Frank G, Bös, Michael, Sleight, Andrew J

Source: British Journal of Pharmacology; Dec1998, Vol. 125 Issue 7, p1562-1566, 5p

Characterization of Ro 04-6790 and Ro 63-0563: potent and selective antagonists at human and rat 5-HT6 receptors.

Authors: Sleight, Andrew J, Boess, Frank G, Bös, Michael, Levet-Trafit, Bernard, Riemer, Claus, Bourson, Anne

Source: British Journal of Pharmacology; Jun1998, Vol. 124 Issue 3, p556-562, 7p

Correlation between 5-HT7 receptor affinity and protection against sound-induced seizures in DBA/2J mice.

Authors: Bourson, Anne, Kapps, Véronique, Zwingelstein, Catherine, Rudler, Alain, Boess, Frank G., Sleight, A. J.

Source: Naunyn-Schmiedeberg's Archives of Pharmacology; Dec1997, Vol. 356 Issue 6, p820-826, 7p

Identification of Residues in Transmembrane Regions III and VI that Contribute to the Ligand Binding Site of the Serotonin 5-HT6 Receptor.

Authors: Boess, Frank G., Monsma, Frederick J., Sleight, Andrew J.

Source: Journal of Neurochemistry; Nov1998, Vol. 71 Issue 5, p2169-2177, 9p